Story Summary: The meeting recognised that while pharmacogenetics and genetics have great potential in helping the biopharmaceutical industry overcome its many challenges, early clinical collaboration between companies, academia, regulators and payers is now needed. The company will over the coming months be attending several conferences in the UK, Europe and the US to highlight its pharmacogenetics expertise. Given the genetic resources of its founding partners, London Genetics has broad therapeutic experience with a focus on cardiovascular drugs and cardiovascular safety. com/Notes to Editors:About London Genetics London Genetics Limited is a not-for-profit company which expedites pharmacogenetic and biomarker partnerships between industry and academia for more effective targeted drug development, and addition of value to marketed medicines. Established in 2007 with funding from the London Development Agency, its seven founding partners are leading academic and medical institutions with clinical and genetic expertise and significant patient resources. Recent agreements developed by London Genetics include a collaboration between the International Serious Adverse Events Consortium, University of and the Drug Safety Research Unit at . The parties are working on genetic markers for drug-induced cardiac arrhythmia. About pharmacogenetics Genetic differences between individuals means that drug response rates are often variable across a population, and this has significant healthcare cost effectiveness implications. Pharmocogenetics, the study of the clinical consequences of genetic differences in the way people metabolise and respond to drugs, is expected to generate better understanding of how drugs work in the body, and therefore give insight into how to develop more efficacious and safer drugs. It also has implications for product life cycle management and the revitalisation of drugs which previously failed in clinical trials. The FDA and the EMEA have recognised this in their Critical Path Initiative and Road Map respectively….Read the Full Story

Related posts:

1. Research partnership will study how electronic medical records can address genetics of drug safety
2. Inovio Biomedical to Present at Partnering and Vaccine Conferences
3. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
4. Wayne State University To Lead First Ever Combined Imaging And Genetics Study In Childhood OCD
5. Contact tracing successful at diagnosing HIV in partners of those with acute infection